S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
The single greatest medical breakthrough of all time? (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
The single greatest medical breakthrough of all time? (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
The single greatest medical breakthrough of all time? (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
The single greatest medical breakthrough of all time? (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
The UN's top tech official discusses AI, bringing the world together and what keeps him up at night

DocuSign (DOCU) Stock Forecast, Price & News

$41.50
-0.69 (-1.64%)
(As of 09/22/2023 08:51 PM ET)
Compare
Today's Range
$41.41
$42.64
50-Day Range
$41.50
$54.18
52-Week Range
$39.57
$69.45
Volume
2.67 million shs
Average Volume
3.94 million shs
Market Capitalization
$8.43 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$61.69

DocuSign MarketRank™ Forecast

Analyst Rating
Reduce
1.92 Rating Score
Upside/​Downside
48.7% Upside
$61.69 Price Target
Short Interest
Healthy
4.26% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.68
Upright™ Environmental Score
News Sentiment
0.70mentions of DocuSign in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$5.65 M Sold Last Quarter
Proj. Earnings Growth
-10.26%
From $0.39 to $0.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.48 out of 5 stars

Business Services Sector

78th out of 307 stocks

Prepackaged Software Industry

45th out of 200 stocks


DOCU stock logo

About DocuSign (NASDAQ:DOCU) Stock

DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; and Monitor that uses advanced analytics to track DocuSign eSignature web, mobile, and API account. In addition, the company offers Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; DocuSign Federal and DocuSign CLM are FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and web-based self-service purchasing. The company was incorporated in 2003 and is headquartered in San Francisco, California.

DOCU Price History

DOCU Stock News Headlines

MarketBeat Week in Review – 9/4 - 9/8 (DOCU)
This market continues to be filled with contradictions, but the MarketBeat team is here to help you find the opportunities that continue to exist
This Beaten Down Stock Just Flashed 2 Buy Signals
Despite being all time lows, things are starting to look good. Docusign reported its Q2 earnings last night which flashed two very strong buy signals.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Reviewing DocuSign (NASDAQ:DOCU) & Everbridge (NASDAQ:EVBG)
DocuSign (NASDAQ:DOCU) Now Covered by Analysts at HSBC
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
DocuSign (NASDAQ:DOCU) PT Raised to $87.00 at Citigroup
Analyst Expectations for DocuSign's Future
Why DocuSign (DOCU) is a Top Growth Stock for the Long-Term
DocuSign: Still Searching For Cycle Bottom
DocuSign, Inc.: Maintaining HOLD after 2Q24 results
Barron's Weekend Stock Picks: Coca-Cola, Groupon And DocuSign's Dilemma
DocuSign shares rise after earnings, and other movers
See More Headlines
Receive DOCU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocuSign and its competitors with MarketBeat's FREE daily newsletter.

DOCU Company Calendar

Last Earnings
9/07/2023
Today
9/24/2023
Next Earnings (Estimated)
12/14/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:DOCU
Fax
N/A
Employees
7,336
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$61.69
High Stock Price Forecast
$87.00
Low Stock Price Forecast
$42.00
Forecasted Upside/Downside
+48.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.92
Research Coverage
13 Analysts

Profitability

Net Income
$-97,450,000.00
Pretax Margin
0.21%

Debt

Sales & Book Value

Annual Sales
$2.52 billion
Cash Flow
$1.17 per share
Book Value
$4.17 per share

Miscellaneous

Free Float
167,035,000
Market Cap
$8.43 billion
Optionable
Optionable
Beta
0.90
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Allan C. Thygesen (Age 60)
    CEO & Director
    Comp: $1.4M
  • Ms. Inhi Cho Suh (Age 47)
    Pres of Product & Technology
    Comp: $865k
  • Mr. James P. Shaughnessy Esq. (Age 68)
    Chief Legal Officer
    Comp: $694.07k
  • Mr. Stephen ShuteMr. Stephen Shute (Age 52)
    Pres of Worldwide Field Operations
    Comp: $759.62k
  • Mr. Robert Chatwani (Age 47)
    Pres & GM of Growth
  • Mr. Blake Jeffrey Grayson (Age 50)
    Exec. VP & CFO
  • Mr. Anwar Akram
    Chief Operating Officer
  • Ms. Shanthi Iyer
    Chief Information Officer
  • Heather Kalista Harwood
    Head of Investor Relations
  • Ms. Jennifer Christie
    Chief People Officer













DOCU Stock - Frequently Asked Questions

Should I buy or sell DocuSign stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DocuSign in the last twelve months. There are currently 4 sell ratings, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" DOCU shares.
View DOCU analyst ratings
or view top-rated stocks.

What is DocuSign's stock price forecast for 2023?

13 analysts have issued twelve-month price objectives for DocuSign's shares. Their DOCU share price forecasts range from $42.00 to $87.00. On average, they predict the company's share price to reach $61.69 in the next year. This suggests a possible upside of 48.7% from the stock's current price.
View analysts price targets for DOCU
or view top-rated stocks among Wall Street analysts.

How have DOCU shares performed in 2023?

DocuSign's stock was trading at $55.42 at the beginning of the year. Since then, DOCU stock has decreased by 25.1% and is now trading at $41.50.
View the best growth stocks for 2023 here
.

Are investors shorting DocuSign?

DocuSign saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 8,660,000 shares, an increase of 14.4% from the August 15th total of 7,570,000 shares. Based on an average daily volume of 3,970,000 shares, the days-to-cover ratio is presently 2.2 days.
View DocuSign's Short Interest
.

When is DocuSign's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 14th 2023.
View our DOCU earnings forecast
.

How were DocuSign's earnings last quarter?

DocuSign, Inc. (NASDAQ:DOCU) released its earnings results on Thursday, September, 7th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.66 by $0.06. The business had revenue of $687.69 million for the quarter, compared to analyst estimates of $677.56 million. DocuSign had a positive trailing twelve-month return on equity of 11.30% and a negative net margin of 0.64%. The business's revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.18) EPS.

What guidance has DocuSign issued on next quarter's earnings?

DocuSign updated its FY 2024 earnings guidance on Thursday, September, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.73 billion-$2.74 billion, compared to the consensus revenue estimate of $2.72 billion.

What is Daniel Springer's approval rating as DocuSign's CEO?

782 employees have rated DocuSign Chief Executive Officer Daniel Springer on Glassdoor.com. Daniel Springer has an approval rating of 98% among the company's employees. This puts Daniel Springer in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of DocuSign own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DocuSign investors own include NVIDIA (NVDA), Block (SQ), Tesla (TSLA), Advanced Micro Devices (AMD), Zoom Video Communications (ZM), PayPal (PYPL), Salesforce (CRM), Alibaba Group (BABA), Shopify (SHOP) and Netflix (NFLX).

When did DocuSign IPO?

(DOCU) raised $542 million in an initial public offering (IPO) on Friday, April 27th 2018. The company issued 21,700,000 shares at a price of $24.00-$26.00 per share. Morgan Stanley and J.P. Morgan served as the underwriters for the IPO and Citigroup, BofA Merrill Lynch, Deutsche Bank Securities, JMP Securities, Pper Jaffray and William Blair were co-managers.

What is DocuSign's stock symbol?

DocuSign trades on the NASDAQ under the ticker symbol "DOCU."

Who are DocuSign's major shareholders?

DocuSign's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (3.74%), Capital International Investors (2.26%), Capital World Investors (2.12%), Newlands Management Operations LLC (2.04%), Geode Capital Management LLC (1.46%) and Clearbridge Investments LLC (1.39%). Insiders that own company stock include Cynthia Gaylor, Daniel D Springer, Enrique T Salem, Enrique T Salem, Loren Alhadeff, Peter Solvik, Scott V Olrich, Stephen Shute, Teresa Briggs and Tram T Phi.
View institutional ownership trends
.

How do I buy shares of DocuSign?

Shares of DOCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DocuSign's stock price today?

One share of DOCU stock can currently be purchased for approximately $41.50.

How much money does DocuSign make?

DocuSign (NASDAQ:DOCU) has a market capitalization of $8.43 billion and generates $2.52 billion in revenue each year. The company earns $-97,450,000.00 in net income (profit) each year or ($0.09) on an earnings per share basis.

How many employees does DocuSign have?

The company employs 7,336 workers across the globe.

How can I contact DocuSign?

DocuSign's mailing address is 221 Main St. Suite 1550, San Francisco CA, 94105. The official website for the company is www.docusign.com. The company can be reached via phone at (415) 489-4940 or via email at investors@docusign.com.

This page (NASDAQ:DOCU) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -